Lawrence Joseph Stack - 04 Jun 2026 Form 3 Insider Report for Quantinuum Inc. (QNT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
04 Jun 2026, 19:18:46 UTC
Prior SEC filing
02 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rajeeb Hazra, Attorney-in-Fact

Key filing fact

Lawrence Joseph Stack filed Form 3 for Quantinuum Inc. (QNT) on 04 Jun 2026.

Key facts

  • This page summarizes Lawrence Joseph Stack's Form 3 filing for Quantinuum Inc. (QNT).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Jun 2026, 19:18.

Change

  • Previous filing in this sequence was filed on 02 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002011273 Primary reporting owner

Stack Lawrence Joseph

Relationship
Chief Commercial Officer
Address
C/O QUANTINUUM INC., 303 S TECHNOLOGY COURT, BROOMFIELD
Signature
/s/ Rajeeb Hazra, Attorney-in-Fact
Signature date
04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QNT holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
178,337
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of restricted stock.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .